102 related articles for article (PubMed ID: 38726798)
1. Novel carbamodithioate regulates cellular hypoxia through chemical activation of prolyl hydroxylase-2 for breast cancer chemoprevention.
Rastogi S; Ansari MN; Saeedan AS; Yadav S; Kumar D; Singh SK; Mukerjee A; Singh M; Kaithwas G
Chem Biol Drug Des; 2024 May; 103(5):e14531. PubMed ID: 38726798
[TBL] [Abstract][Full Text] [Related]
2. Novel furan chalcone modulates PHD-2 induction to impart antineoplastic effect in mammary gland carcinoma.
Rastogi S; Ansari MN; Saeedan AS; Singh SK; Mukerjee A; Kaithwas G
J Biochem Mol Toxicol; 2024 Apr; 38(4):e23679. PubMed ID: 38486411
[TBL] [Abstract][Full Text] [Related]
3. Activation of prolyl hydroxylase-2 for stabilization of mitochondrial stress along with simultaneous downregulation of HIF-1α/FASN in ER + breast cancer subtype.
Devi U; Singh M; Roy S; Gupta PS; Ansari MN; Saeedan AS; Kaithwas G
Cell Biochem Funct; 2019 Jun; 37(4):216-227. PubMed ID: 30950543
[TBL] [Abstract][Full Text] [Related]
4. PHD-2 activation: a novel strategy to control HIF-1α and mitochondrial stress to modulate mammary gland pathophysiology in ER+ subtype.
Devi U; Singh M; Roy S; Tripathi AC; Gupta PS; Saraf SK; Ansari MN; Saeedan AS; Kaithwas G
Naunyn Schmiedebergs Arch Pharmacol; 2019 Oct; 392(10):1239-1256. PubMed ID: 31154466
[TBL] [Abstract][Full Text] [Related]
5. Chemical activation of prolyl hydroxylase-2 by BBAP-1 down regulates hypoxia inducible factor-1α and fatty acid synthase for mammary gland chemoprevention.
Singh M; Devi U; Roy S; Gupta PS; Kaithwas G
RSC Adv; 2018 Apr; 8(23):12848-12860. PubMed ID: 35541235
[TBL] [Abstract][Full Text] [Related]
6. Prolyl hydroxylase mediated inhibition of fatty acid synthase to combat tumor growth in mammary gland carcinoma.
Singh M; Devi U; Roy S; Gupta PS; Saraf SA; Kaithwas G
Breast Cancer; 2016 Nov; 23(6):820-829. PubMed ID: 26951539
[TBL] [Abstract][Full Text] [Related]
7. Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity.
Guise CP; Abbattista MR; Anderson RF; Li D; Taghipouran R; Tsai A; Lee SJ; Smaill JB; Denny WA; Hay MP; Wilson WR; Hicks KO; Patterson AV
Molecules; 2020 Oct; 25(21):. PubMed ID: 33105798
[TBL] [Abstract][Full Text] [Related]
8. Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases.
Chan MC; Ilott NE; Schödel J; Sims D; Tumber A; Lippl K; Mole DR; Pugh CW; Ratcliffe PJ; Ponting CP; Schofield CJ
J Biol Chem; 2016 Sep; 291(39):20661-73. PubMed ID: 27502280
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Siah ubiquitin ligase function.
Möller A; House CM; Wong CS; Scanlon DB; Liu MC; Ronai Z; Bowtell DD
Oncogene; 2009 Jan; 28(2):289-96. PubMed ID: 18850011
[TBL] [Abstract][Full Text] [Related]
10. Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway.
Zhang J; Cao J; Weng Q; Wu R; Yan Y; Jing H; Zhu H; He Q; Yang B
PLoS One; 2010 Nov; 5(11):e13910. PubMed ID: 21085474
[TBL] [Abstract][Full Text] [Related]
11. Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
Hou P; Kuo CY; Cheng CT; Liou JP; Ann DK; Chen Q
PLoS One; 2014; 9(11):e113865. PubMed ID: 25420025
[TBL] [Abstract][Full Text] [Related]
12. Regulation of hypoxia-induced mRNA expressions of HIF-1alpha and osteopontin and in vitro radiosensitization by tirapazamine in human nasopharyngeal carcinoma HNE-1 and CNE-1 cells.
Xu P; Huang JM; Ren Y; Zha X; Deng BF; Wu JH; Lang JY
Chin J Cancer; 2010 Feb; 29(2):126-30. PubMed ID: 20109337
[TBL] [Abstract][Full Text] [Related]
13. β-N-oxalyl-L-α, β- diaminopropionic acid induces HRE expression by inhibiting HIF-prolyl hydroxylase-2 in normoxic conditions.
Eslavath RK; Sharma D; Bin Omar NAM; Chikati R; Teli MK; Rajanikant GK; Singh SS
Eur J Pharmacol; 2016 Nov; 791():405-411. PubMed ID: 27393459
[TBL] [Abstract][Full Text] [Related]
14. Prolyl hydroxylase domain enzymes and their role in cell signaling and cancer metabolism.
Nguyen TL; Durán RV
Int J Biochem Cell Biol; 2016 Nov; 80():71-80. PubMed ID: 27702652
[TBL] [Abstract][Full Text] [Related]
15. The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
Fox SB; Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Bersiga A; Allevi G; Milani M; Aguggini S; Mele T; Dogliotti L; Bottini A; Harris AL
Breast Cancer Res; 2011 Feb; 13(1):R16. PubMed ID: 21291529
[TBL] [Abstract][Full Text] [Related]
16. Effect of Voacamine upon inhibition of hypoxia induced fatty acid synthesis in a rat model of methyln-nitrosourea induced mammary gland carcinoma.
Singh L; Singh M; Rastogi S; Choudhary A; Kumar D; Raj R; Ansari MN; Saeedan AS; Kaithwas G
BMC Mol Cell Biol; 2021 Jun; 22(1):33. PubMed ID: 34090331
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury.
Yang Y; Yu X; Zhang Y; Ding G; Zhu C; Huang S; Jia Z; Zhang A
Clin Sci (Lond); 2018 Apr; 132(7):825-838. PubMed ID: 29581249
[TBL] [Abstract][Full Text] [Related]
18. Prolyl hydroxylase-1 regulates hepatocyte apoptosis in an NF-κB-dependent manner.
Fitzpatrick SF; Fábián Z; Schaible B; Lenihan CR; Schwarzl T; Rodriguez J; Zheng X; Li Z; Tambuwala MM; Higgins DG; O'Meara Y; Slattery C; Manresa MC; Fraisl P; Bruning U; Baes M; Carmeliet P; Doherty G; von Kriegsheim A; Cummins EP; Taylor CT
Biochem Biophys Res Commun; 2016 Jun; 474(3):579-586. PubMed ID: 27130823
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation.
Hong B; Lui VW; Hui EP; Ng MH; Cheng SH; Sung FL; Tsang CM; Tsao SW; Chan AT
Invest New Drugs; 2011 Jun; 29(3):401-10. PubMed ID: 20013349
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel induced-JNK2/PHD1 signaling pathway increases degradation of HIF-1α and causes cancer cell death under hypoxia.
Oh ET; Kim CW; Kim SJ; Lee JS; Hong SS; Park HJ
Sci Rep; 2016 Jun; 6():27382. PubMed ID: 27263528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
